tiprankstipranks
Analyst Profile
Followed by 39 other investors
.
Naureen Quibria

Naureen Quibria

Maxim Group
Wall Street Analyst
Ranked #7,962 out of 8,054 Analysts on TipRanks (#21,182 out of 21,594 overall experts)

Success Rate

24%
18 out of 75 Profitable Transactions

Average Return

-28.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Naureen Quibria's ratings since 2020 and opened each position for the duration of 1 Year:
24.00% of your transactions would have been profitable with an average return of -28.0%

Stock Rating Distribution

103Ratings
91.26% Buy
8.74% Hold
0.00% Sell
Distribution of Naureen Quibria's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market
CanadaCanadian Market
GermanyGermany Market

Best Rating

Stock:
Kintara Therapeutics Inc
(KTRA)
Rating Type:Buy
Dates:Jun 23, 2020 - Jun 23, 2021
Gain:183.90%
The most profitable rating made by Naureen Quibria

Naureen Quibria's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Achieve Life Sciences
Jun 29, 2020
Buy
Initiated
$2.00
(-61.09% Downside)
100%
+16.80%
1
Entera Bio
Jul 23, 2020
Buy
Reiterated
$8.00
(351.98% Upside)
100%
+141.30%
1
Kintara Therapeutics
Jul 27, 2020
Buy
Assigned
$2.00
(1009.88% Upside)
100%
+115.95%
2
Indaptus Therapeutics
Aug 05, 2020
Hold
Assigned
0.00%
1
Aptose Biosciences
Aug 05, 2020
Buy
Assigned
$12.00
(1295.35% Upside)
0%
-51.20%
1
Galmed Pharmaceuticals
Aug 06, 2020
Buy
Reiterated
$10.00
(2027.66% Upside)
0%
-33.60%
1
Bioline RX Ltd Sponsored ADR
Aug 06, 2020
Buy
Reiterated
$5.00
(179.33% Upside)
100%
+64.90%
1
Bluebird Bio
Aug 06, 2020
Buy
Reiterated
$130.00
(1875.68% Upside)
0%
-60.70%
1
ADMA Biologics
Aug 06, 2020
Buy
Assigned
$6.00
(150.00% Upside)
0%
-44.60%
1
Inmune Bio
Aug 06, 2020
Buy
Reiterated
$16.00
(70.21% Upside)
100%
+24.50%
2
List of latest recommendations made by Naureen Quibria. Click to expand and see Naureen Quibria's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More